Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.03 | 0.00 | -0.10 |
| FCF Yield | -163.70% | 213.97% | -553.76% | -74.61% |
| EV / EBITDA | -1.73 | -3.81 | -3.43 | 1.72 |
| Quality | ||||
| ROIC | -13.17% | -5.10% | -7.48% | 1.92% |
| Gross Margin | 38.46% | 26.17% | 19.39% | 20.89% |
| Cash Conversion Ratio | 0.32 | -1.37 | 2.70 | -2.44 |
| Growth | ||||
| Revenue 3-Year CAGR | -31.86% | -26.02% | -11.50% | 2.10% |
| Free Cash Flow Growth | -138.35% | 138.44% | -125.99% | -625.48% |
| Safety | ||||
| Net Debt / EBITDA | -1.51 | -2.74 | -2.84 | -0.80 |
| Interest Coverage | -8.51 | -4.51 | -7.20 | 2.09 |
| Efficiency | ||||
| Inventory Turnover | 1.98 | 3.07 | 3.37 | 3.89 |
| Cash Conversion Cycle | 176.67 | 151.62 | 134.31 | 59.80 |